Our primary concern at Novartis remains the health and safety of our associates and patients globally ...
Novartis making history in blood cancer for decades
Our primary concern at Novartis remains the health and safety of our associates and patients globally, and it is ...
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Novartis focuses its business on three leading divisions on a global scale: pharmaceuticals, eye care and generics.
